Raymond James & Associates’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $481K | Sell |
6,891
-252
| -4% | -$17.6K | ﹤0.01% | 3121 |
|
|
2024
Q2 | $463K | Buy |
7,143
+167
| +2% | +$10.8K | ﹤0.01% | 3100 |
|
|
2024
Q1 | $451K | Sell |
6,976
-6,271
| -47% | -$406K | ﹤0.01% | 3091 |
|
|
2023
Q4 | $872K | Buy |
13,247
+7,268
| +122% | +$479K | ﹤0.01% | 2590 |
|
|
2023
Q3 | $341K | Sell |
5,979
-600
| -9% | -$34.2K | ﹤0.01% | 3102 |
|
|
2023
Q2 | $403K | Buy |
6,579
+453
| +7% | +$27.8K | ﹤0.01% | 3046 |
|
|
2023
Q1 | $385K | Buy |
6,126
+198
| +3% | +$12.4K | ﹤0.01% | 3051 |
|
|
2022
Q4 | $376K | Sell |
5,928
-282
| -5% | -$17.9K | ﹤0.01% | 3061 |
|
|
2022
Q3 | $366K | Buy |
6,210
+731
| +13% | +$43.1K | ﹤0.01% | 3041 |
|
|
2022
Q2 | $316K | Sell |
5,479
-6
| -0.1% | -$346 | ﹤0.01% | 3184 |
|
|
2022
Q1 | $340K | Buy |
5,485
+127
| +2% | +$7.87K | ﹤0.01% | 3312 |
|
|
2021
Q4 | $382K | Sell |
5,358
-898
| -14% | -$64K | ﹤0.01% | 3276 |
|
|
2021
Q3 | $468K | Sell |
6,256
-852
| -12% | -$63.7K | ﹤0.01% | 3100 |
|
|
2021
Q2 | $550K | Hold |
7,108
| – | – | ﹤0.01% | 3003 |
|
|
2021
Q1 | $525K | Sell |
7,108
-270
| -4% | -$19.9K | ﹤0.01% | 2961 |
|
|
2020
Q4 | $517K | Sell |
7,378
-6,393
| -46% | -$448K | ﹤0.01% | 2770 |
|
|
2020
Q3 | $780K | Sell |
13,771
-122
| -0.9% | -$6.91K | ﹤0.01% | 2322 |
|
|
2020
Q2 | $810K | Buy |
13,893
+5,162
| +59% | +$301K | ﹤0.01% | 2292 |
|
|
2020
Q1 | $406K | Sell |
8,731
-810
| -8% | -$37.7K | ﹤0.01% | 2557 |
|
|
2019
Q4 | $533K | Sell |
9,541
-7,014
| -42% | -$392K | ﹤0.01% | 2670 |
|
|
2019
Q3 | $784K | Buy |
16,555
+571
| +4% | +$27K | ﹤0.01% | 2334 |
|
|
2019
Q2 | $855K | Sell |
15,984
-34,712
| -68% | -$1.86M | ﹤0.01% | 2304 |
|
|
2019
Q1 | $2.8M | Buy |
50,696
+653
| +1% | +$36K | ﹤0.01% | 1553 |
|
|
2018
Q4 | $2.36M | Buy |
50,043
+36,991
| +283% | +$1.74M | ﹤0.01% | 1550 |
|
|
2018
Q3 | $776K | Buy |
13,052
+1,435
| +12% | +$85.3K | ﹤0.01% | 2415 |
|
|
2018
Q2 | $636K | Buy |
11,617
+540
| +5% | +$29.6K | ﹤0.01% | 2515 |
|
|
2018
Q1 | $545K | Buy |
11,077
+360
| +3% | +$17.7K | ﹤0.01% | 2503 |
|
|
2017
Q4 | $505K | Sell |
10,717
-1,150
| -10% | -$54.2K | ﹤0.01% | 2519 |
|
|
2017
Q3 | $593K | Sell |
11,867
-32
| -0.3% | -$1.6K | ﹤0.01% | 2377 |
|
|
2017
Q2 | $543K | Buy |
11,899
+1,332
| +13% | +$60.8K | ﹤0.01% | 2360 |
|
|
2017
Q1 | $447K | Sell |
10,567
-1,208
| -10% | -$51.1K | ﹤0.01% | 2449 |
|
|
2016
Q4 | $457K | Buy |
11,775
+35
| +0.3% | +$1.36K | ﹤0.01% | 2384 |
|
|
2016
Q3 | $493K | Sell |
11,740
-1,734
| -13% | -$72.8K | ﹤0.01% | 2290 |
|
|
2016
Q2 | $498K | Buy |
13,474
+780
| +6% | +$28.8K | ﹤0.01% | 2107 |
|
|
2016
Q1 | $486K | Buy |
12,694
+1,657
| +15% | +$63.4K | ﹤0.01% | 2056 |
|
|
2015
Q4 | $558K | Sell |
11,037
-19,481
| -64% | -$985K | ﹤0.01% | 1933 |
|
|
2015
Q3 | $1.4M | Sell |
30,518
-4,907
| -14% | -$224K | 0.01% | 1421 |
|
|
2015
Q2 | $2.07M | Buy |
35,425
+1,055
| +3% | +$61.6K | 0.01% | 1293 |
|
|
2015
Q1 | $1.9M | Sell |
34,370
-566
| -2% | -$31.2K | 0.01% | 1268 |
|
|
2014
Q4 | $1.75M | Sell |
34,936
-1,151
| -3% | -$57.8K | 0.01% | 1233 |
|
|
2014
Q3 | $1.67M | Sell |
36,087
-1,237
| -3% | -$57.2K | 0.01% | 1185 |
|
|
2014
Q2 | $1.63M | Buy |
37,324
+3,085
| +9% | +$135K | 0.01% | 1209 |
|
|
2014
Q1 | $1.43M | Buy |
34,239
+2,463
| +8% | +$103K | 0.01% | 1220 |
|
|
2013
Q4 | $1.18M | Buy |
31,776
+14,333
| +82% | +$531K | 0.01% | 1237 |
|
|
2013
Q3 | $612K | Sell |
17,443
-988
| -5% | -$34.7K | 0.01% | 1500 |
|
|
2013
Q2 | $532K | Buy |
+18,431
| New | +$532K | 0.01% | 1488 |
|